AstraZeneca Announces Construction of Radiopharmaceutical Conjugate Drug Production and Supply Base in Guangzhou

People’s Financial News, March 19 — On March 19, AstraZeneca signed a memorandum of understanding with the Guangzhou Economic and Technological Development Zone Management Committee, announcing plans to build a radioactive conjugated drug production and supply base in Guangzhou. The facility will specifically produce radioactive conjugated drugs to provide next-generation cancer therapies for patients in China and the broader Asia-Pacific region. Recently, AstraZeneca also announced plans to establish a cell therapy production and supply base in Shanghai.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments